Aikeruisi secures tens of millions in Series A+ financing

36Kr learned from the official WeChat account of Acris that on August 22, "Acris" and "Shaoxing Ruinucleus" successfully completed the investment signing ceremony in Hangzhou. "Acris" received tens of millions of yuan in financing. The funds from this round of financing will mainly be used to accelerate the clinical phase Ib/IIa trial of the ACR246 project and the preclinical research of other ADC drugs.